BioTime, Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BioTime with three other
companies in this sector in the United States:
Adma Biologics Inc
sales of $7.18 million
of which 98%
was Plasma Collection Center),
of which 100%
was Therapeutic Drug Dev), and
BioTime reported sales of $7.04 million
December of 2015.
increase of 34.2%
versus 2014, when the company's sales were $5.24 million.
This was the third consecutive year of growth at BioTime.